| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.327 | 1.804 | 2.386 | 2.665 | 2.809 | 817 | 3.532 | 5.485 | 4.392 | 6.053 |
| Total Income - EUR | 1.327 | 1.804 | 2.386 | 2.665 | 2.809 | 817 | 3.532 | 5.485 | 4.392 | 6.053 |
| Total Expenses - EUR | 326 | 0 | 0 | 26 | 52 | 51 | 182 | 186 | 1.533 | 3.311 |
| Gross Profit/Loss - EUR | 1.001 | 1.804 | 2.386 | 2.638 | 2.757 | 765 | 3.350 | 5.299 | 2.859 | 2.742 |
| Net Profit/Loss - EUR | 961 | 1.750 | 2.315 | 2.558 | 2.672 | 741 | 3.244 | 5.134 | 2.452 | 2.304 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Xx-Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 2.106 | 2.012 | 1.923 | 3.788 | 3.496 | 4.528 | 3.645 |
| Current Assets | 3.236 | 4.965 | 7.192 | 7.530 | 10.112 | 10.706 | 11.772 | 17.209 | 14.880 | 17.741 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 975 |
| Receivables | 2.542 | 2.516 | 2.474 | 296 | 4.505 | 4.420 | 4.322 | 4.335 | 8.921 | 8.964 |
| Cash | 694 | 2.449 | 4.719 | 7.234 | 5.607 | 6.287 | 7.450 | 12.874 | 5.959 | 7.802 |
| Shareholders Funds | 3.056 | 4.774 | 7.008 | 9.438 | 11.927 | 12.442 | 15.409 | 20.591 | 19.190 | 21.386 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 181 | 191 | 185 | 198 | 198 | 188 | 150 | 113 | 219 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Xx-Med S.r.l.